Brenner AV, Preston DL, Sakata R, Sugiyama H, Berrington de Gonzalez A, French B, et al. “Incidence of breast cancer in the life span study of atomic bomb survivors: 1958- 2009.” Radiat Res. 2018;190(4):433-44.
Brenner AV, Sugiyama H, Preston DL, Sakata R, French B, Sadakane A, et al. “Radiation risk of central nervous system tumors in the life span study of atomic bomb survivors, 1958-2009.” Eur J Epidemiol. 2020;35(6):591-600.
Brenner AV, Preston DL, Sakata R, Cologne J, Sugiyama H, Utada M, et al. “Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.” Radiat Res. 2022;197(5):491-508.
Cahoon EK, Preston DL, Pierce DA, Grant E, Brenner AV, Mabuchi K, et al. “Lung, Laryngeal and other respiratory cancer incidence among Japanese atomic bomb survivors: an updated analysis from 1958 through 2009.” Radiat Res. 2017;187(5):538- 48.
Cologne JB, Preston DL. “Longevity of atomic-bomb survivors.” Lancet. 2000;356(9226): 303-7.
Cologne J, Kim J, Sugiyama H, French B, Cullings HM, Preston DL, et al. “Effect of heterogeneity in background incidence on inference about the solid-cancer radiation dose response in atomic bomb survivors.” Radiat Res. 2019;192(4):388-98.
Cologne J, Sugiyama H, Hamasaki K, Tatsukawa Y, French B, Sakata R, et al. “Chromosome aberrations among atomic-bomb survivors exposed in utero: updated analysis accounting for revised radiation doses and smoking.” Radiat Environ Biophys. 2022;61(1):59-72.
Egawa H, Furukawa K, Preston D, Funamoto S, Yonehara S, Matsuo T, et al. “Radiation and smoking effects on lung cancer incidence by histological types among atomic bomb survivors.” Radiat Res. 2012;178(3):191-201.
French B, Cologne J, Sakata R, Utada M, Preston DL. “Selection of reference groups in the life span study of atomic bomb survivors.” Eur J Epidemiol. 2017;32(12):1055-63.
French B, Funamoto S, Sugiyama H, Sakata R, Cologne J, Cullings HM, et al. “Population density in Hiroshima and Nagasaki before the bombings in 1945: its measurement and impact on radiation risk estimates in the life span study of atomic bomb survivors.” Am J Epidemiol. 2018;187(8):1623-9.
Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, et al. “Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.” Int J Cancer. 2013;132(5):1222-6.
Fujihara M, Sakata R, Yoshida N, Ozasa K, Preston DL, Mabuchi K. “Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994.” Blood. 2022;139(2):217-27.
Grant EJ, Furukawa K, Sakata R, Sugiyama H, Sadakane A, Takahashi I, et al. “Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.” Lancet Oncol. 2015;16(13):1316-23.
Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, et al. “Solid cancer incidence among the life span study of atomic bomb survivors: 1958-2009.” Radiat Res. 2017;187(5):513-37.
Horai M, Mishima H, Hayashida C, Kinoshita A, Nakane Y, Matsuo T, et al. “Detection of de novo single nucleotide variants in offspring of atomic-bomb survivors close to the hypocenter by whole-genome sequencing.” J Hum Genet. 2018;63(3):357-63.
Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. “The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.” Radiat Res. 2013;179(3):361-82.
Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, et al. “Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.” JAMA. 2006;295(9):1011-22.
Kamiya K, Ozasa K, Akiba S, Niwa O, Kodama K, Takamura N, et al. “Long-term effects of radiation exposure on health.” Lancet. 2015;386(9992):469-78.
Little MP. “Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.” Int J Radiat Biol. 2002;78(11):1001-10.
Ohtaki K, Kodama Y, Nakano M, Itoh M, Awa AA, Cologne J, et al. “Human fetuses do not register chromosome damage inflicted by radiation exposure in lymphoid precursor cells except for a small but significant effect at low doses.” Radiat Res. 2004;161(4):373-9.
Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, et al. “Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.” Radiat Res. 2012;177(3):229-43.
Ozasa K, Sakata R, Cullings HM, Grant EJ. “Association of acute radiation syndrome and rain after the bombings in atomic bomb survivors.” Radiat Res. 2016;185(6):604- 15.
Ozasa K, Cullings HM, Ohishi W, Hida A, Grant EJ. “Epidemiological studies of atomic bomb radiation at the Radiation Effects Research Foundation.” Int J Radiat Biol. 2019;95(7):879-91.
Pierce DA, Vaeth M, Shimizu Y. “Selection bias in cancer risk estimation from a-bomb survivors.” Radiat Res. 2007;167(6):735-41.
Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. “Solid cancer incidence in atomic bomb survivors: 1958-1998.” Radiat Res. 2007;168(1):1-64.
Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. “Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.” J Natl Cancer Inst. 2008;100:428-36.
Richardson DB, Wing S. “Greater sensitivity to ionizing radiation at older age: follow- up of workers at Oak Ridge National Laboratory through 1990.” Int J Epidemiol. 1999;28(3):428-36.
Sakata R, Grant EJ, Furukawa K, Misumi M, Cullings H, Ozasa K, et al. “Long-term effects of the rain exposure shortly after the atomic bombings in Hiroshima and Nagasaki.” Radiat Res. 2014;182(6):599-606.
Sugiyama H, Misumi M, Sakata R, Brenner AV, Utada M, Ozasa K. “Mortality among individuals exposed to atomic bomb radiation in utero: 1950-2012.” Eur J Epidemiol. 2021;36(4):415-28.
Takahashi I, Shimizu Y, Grant EJ, Cologne J, Ozasa K, Kodama K. “Heart disease mortality in the life span study, 1950-2008.” Radiat Res. 2017;187(3):319-32.
Utada M, Brenner AV, Preston DL, Cologne JB, Sakata R, Sugiyama H, et al. “Radiation risks of uterine cancer in atomic bomb survivors: 1958-2009.” JNCI Cancer Spectr. 2018;2(4):pky081.
Watanabe T, Miyao M, Honda R, Yamada Y. “Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers.” Environ Health Prev Med. 2008;13(5):264-70.
Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. “Noncancer disease incidence in atomic bomb survivors, 1958-1998.” Radiat Res. 2004;161(6):622-32.
Yamada M, Kato N, Kitamura H, Ishihara K, Hida A. “Cognitive function among elderly survivors prenatally exposed to atomic bombings.” Am J Med. 2021;134(4):e264-7.
Yamada M, Furukawa K, Tatsukawa Y, Marumo K, Funamoto S, Sakata R, et al. “Congenital malformations and perinatal deaths among the children of atomic bomb survivors: a reappraisal.” Am J Epidemiol. 2021;190(11):2323-33.